tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
ZVRA
Zevra Therapeutics
RESEARCH TOOLSreports
Want to see ZVRA full AI Analyst Report?

Zevra Therapeutics (ZVRA) Income Statement

1,054 Followers

Zevra Therapeutics Income Statement

Last quarter (Q4 2025), Zevra Therapeutics's total revenue was $34.13M, an increase of 183.36% from the same quarter last year. In Q4, Zevra Therapeutics's net income was $12.16M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 106.47M$ 23.61M$ 27.46M$ 10.16M$ 28.65M
Gross Profit
$ 89.99M$ 16.20M$ 24.52M$ 9.94M$ 26.59M
Operating Expenses
$ 94.22M$ 103.20M$ 74.12M$ 52.50M$ 18.86M
Depreciation and Amortization
$ 4.05M$ 6.39M$ 1.01M$ 944.00K$ 257.00K
EBITDA
$ 98.71M$ -76.40M$ -43.54M$ -25.53M$ -7.89M
Operating Income
$ -4.23M$ -87.00M$ -49.60M$ -42.56M$ 7.73M
Other Income/Expenses
$ 90.91M$ -3.14M$ 3.56M$ 15.76M$ -16.25M
Pretax Income
$ 86.68M$ -90.14M$ -46.05M$ -26.80M$ -8.52M
Net Income
$ 83.23M$ -105.51M$ -46.05M$ -26.77M$ -8.55M
Per Share Metrics
Basic EPS
$ 1.40$ -2.28$ -1.30$ -0.78$ -2.11
Diluted EPS
$ 1.35$ -2.28$ -1.30$ -0.78$ -2.11
Weighted Average Shares Outstanding
 55.31M 46.25M 35.45M 34.49M 29.77M
Weighted Average Shares Outstanding (Diluted)
 57.26M 46.25M 35.45M 34.49M 29.77M
Currency in USD

Zevra Therapeutics Earnings and Revenue History